Adipose tissue-derived mesenchymal stem cells ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	2

97. 潰瘍性大腸炎

---

臨床試験数 : 2,630 /  薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01914887 (ClinicalTrials.gov)	June 2013	18/7/2013	Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis	A Phase I/IIa Clinical Trial to Evaluate Safety and Efficacy of Adipose Tissue-derived Mesenchymal Stem Cells (ASC) on Induction to Remission in Ulcerative Colitis	Ulcerative Colitis	Drug: Allogeneic adipose tissue-derived mesenchymal stem cells	Instituto de Investigación Hospital Universitario La Paz	Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz;Ministry of Health, Spain	Recruiting	18 Years	N/A	Both	8	Phase 1/Phase 2	Spain
2	EUCTR2010-023798-20-ES (EUCTR)	29/11/2012	10/05/2012	A CLINICAL TRIAL WITH FAT-DERIVED ADULT STEM CELLS TO TREAT ULCERATIVE COLITIS	A PHASE I/IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS (ASC) ON INDUCTION TO REMISSION IN ULCERATIVE COLITIS - ALOASCU	MedDRA version: 14.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Product Name: ASC INN or Proposed INN: adipose tissue-derived mesenchymal stem cells Other descriptive name: aloASC	Fundacion para la Investigacion Biomedica Hospital Universitario La Paz	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 1/2	Spain